Blood Journal
Overview
Publication venue for
- A Phase 1a/b Trial of Luxeptinib (CG-806) in Patients with Relapsed/Refractory B-Cell Malignancies or Acute Myeloid Leukemia and Evaluation of New G3 Formulation. 142. 2023
- Prior Daratumumab Exposure and It's Correlation to Parameters Related to Apheresis Prior to Hematopoietic Stem Cell Transplantation in Multiple Myeloma. 142. 2023
- Racial and Ethnic Differences in Acuity and Cumulative Frontline Organ Toxicity at the Time of Relapse in Pediatric Acute Myeloid Leukemia. 142. 2023
- Survival Disparities By Frontline Clinical Trial Enrollment Status for Treatment of Pediatric Acute Myeloid Leukemia. 142. 2023
- The Nature of High-Risk Defining Events in Follicular Lymphoma Determines Overall Survival. 142. 2023
- Updated Results from Phase 1 Study of Targeted Radiotherapy with Lintuzumab-Ac225 in Combination with Venetoclax in Relapsed/Refractory AML. 142. 2023
- A Case of PNH with Abdominal Pain, AKI and Hemolytic Anemia. 140:11066-11067. 2022
- Early Clinical Evaluation of Potential Synergy of Targeted Radiotherapy with Lintuzumab-Ac225 and Venetoclax in Relapsed/Refractory AML. 140:3336-3337. 2022
- No Evidence of Racial Survival Disparity Gap Among Blacks Vs Whites with Multiple Myeloma Post Autologous Stem Cell Transplant: A Study from over a Decade. 140:13239-13239. 2022
- The Clinical Utility of Acoustic Tweezing Thromboelastometry in Monitoring Blood Coagulation during Liver Transplantation. 140:2805-2806. 2022
- Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant. 137:2585-2597. 2021
- Home or Away from Home: A Multi-Institution Study Comparing Medical Outcomes, Patient Perspectives, and Health-Related Quality of Life for Outpatient Versus Inpatient Management after Chemotherapy for Pediatric Acute Myeloid Leukemia. 134. 2019
- A Phase 2 Study of Actinium-225 (Ac-225)-Lintuzumab in Older Patients with Untreated Acute Myeloid Leukemia (AML) - Interim Analysis of 1.5 mu ci/Kg/Dose. 132. 2018
- Burden of Hospital Readmissions for Venous Thromboembolism Among Patients with Cancer. 132. 2018
- Midostaurin in Adults with Newly Diagnosed FLT3-Mutation-Positive Acute Myeloid Leukemia Eligible for Standard Chemotherapy: Update from the Radius-X Midostaurin Expanded Access Program. 132. 2018
- Zella 201: A Biomarker-Guided Phase II Study of Alvocidib Followed By Cytarabine and Mitoxantrone in MCL-1 Dependent Relapsed/Refractory Acute Myeloid Leukemia (AML). 132. 2018
- Unique Clinical Epidemiologic Risk Factors Are Associated with Distinct Methylation Subgroups in Newly-Diagnosed Acute Myeloid Leukemia (AML). 128. 2016
- Evaluation of Differences in Medical Costs Associated with Venous Thromboembolism Prophylaxis with Desirudin Vs. Low Molecular Weight Heparin Among Patients Undergoing Total Hip Replacement Surgery. 124. 2014
- Association Between Age and Bleeding Events of Different Severities Among Patients with Nonvalvular Atrial Fibrillation in a Managed Care Population. 120. 2012
- Type of Bleeding Among Patients with Nonvalvular Atrial Fibrillation in a Large Managed Care Population. 120. 2012
- Impact of CMS VTE Hospital Acquired Conditions (HAC) Policy on Hospital Cost and Revenue Associated with Major Surgical Hip and Knee Procedures.. 116:1564-1565. 2010
- Pegylated arginase I: a potential therapeutic approach in T-ALL. 115:5214-5221. 2010
- Prelinical Evaluation of Lyn Kinase Inhibition for the Treatment of B Cell Chronic Lymphocytic Leukemia (B-CLL).. 114:1339-1339. 2009
- Prevalence of Venous Thromboembolism Across Ethnic Groups in the United States. 114:983-983. 2009
- Patterns and Predictors of Warfarin Use in Patients with Venous Thromboembolism. 112:1040-1040. 2008
- Protein Kinase C-Epsilon Is An Important Component of the Lyn Kinase Signaling Pathway in the Apoptotic Resistance of B-Chronic Lymphocytic Leukemia Cells. 112:726-726. 2008
Identity
International Standard Serial Number (ISSN)
- 0006-4971